AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
RANCHO MIRAGE, CALIF. -- The fear that combining migraine medication with selective serotonin reuptake inhibitors can increase the risk of serotonin syndrome may be over-stated, Dr. Stewart J. Tepper said at a meeting sponsored by the Diamond Headache Clinic.
This concern, if unfounded, may actually be harming patients because depression, anxiety, and migraine often occur together, and many patients could benefit from taking a selective serotonin reuptake inhibitor (SSRI) and a triptan, said Dr. Tepper, director of the New England Center for Headache, Stamford, Conn.
Serotonin syndrome results from serotonin toxicity associated with use of SSRIs. The symptoms include altered mental status, autonomic dysregulation manifested as changes in vasomotor function and altered vital signs, and neuromuscular changes such as myoclonus, ataxia, and seizures, said Dr. Tepper, also of Yale University, New Haven.
The Food and Drug Administration cautions against the simultaneous use of triptans or ergots with SSRIs, based on anecdotal reports of serotonin syndrome occurring in a few patients who combined those ...
Source: HighBeam Research, SSRIs plus migraine medications: few data for serotonin syndrome...